Shaikh Fathima Aidha, Withers Stephen G
Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, BC V6T1Z1, Canada.
Biochem Cell Biol. 2008 Apr;86(2):169-77. doi: 10.1139/O07-149.
The therapeutic potential of glycosides has made them an attractive target for drug development. The biological extraction and chemical synthesis of these molecules is often challenging and low yielding, thus alternative methods for the synthesis of polysaccharides are being pursued. A new class of enzymes, glycosynthases, which are nucleophile mutants of glycosidases, can perform the transglycosylation reaction without hydrolyzing the product, and thus provide a valuable resource for polysaccharide and glycan synthesis. Directed evolution of glycosynthases has expanded the repertoire of glycosidic linkages formed and the donors and acceptors (both sugar and nonsugar) that can be used by the glycosynthase. The application of new screening methods, such as FACS, to the directed evolution of glycosynthases will aid in the development of enzymes that are able to efficiently synthesize new, and therapeutically relevant glycosidic linkages.
糖苷的治疗潜力使其成为药物开发的一个有吸引力的靶点。这些分子的生物提取和化学合成通常具有挑战性且产率较低,因此人们正在探索合成多糖的替代方法。一类新的酶,即糖基合成酶,它是糖苷酶的亲核突变体,可以进行转糖基化反应而不水解产物,从而为多糖和聚糖的合成提供了宝贵的资源。糖基合成酶的定向进化扩大了所形成的糖苷键的种类以及糖基合成酶可以使用的供体和受体(糖和非糖)。将新的筛选方法,如荧光激活细胞分选术(FACS),应用于糖基合成酶的定向进化,将有助于开发能够有效合成新的、与治疗相关的糖苷键的酶。